Back to Search

RIGL

Rigel Pharmaceuticals Inc. (New)
Data: 2026-07-31
$36.81
Price
-3.28%
Change
$52.24
52W High
$20.28
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Quick Stats
Jul 31, 2026

58.1

AI Score

HOLD

0.46

Volume Ratio

Aug 04, 2026

Next Earnings

16

+ve Days (30d)

14

-ve Days (30d)

RIGL Stock Summary

Last updated Jul 31, 2026

RIGL is currently trading at $36.81, positioned above its 200-day moving average of $34.98, indicating a long-term uptrend. The stock has a 52-week range of $20.2751 to $52.24.

Technical Analysis: The 50-day moving average stands at $35.64, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 44.058, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.062, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RIGL at 58.1/100 with a HOLD recommendation.

RIGL (Rigel Pharmaceuticals Inc. (New)) Indicators

Last updated Jul 31, 2026

Indicator Value
RSI(14) 44.058
CMF (20) 0.062
ROC (10) -9.201
ADX (14) 22.136
Indicator Value
MACD (12,26,9) 0.285
AROONOSC (14) -42.857
WILLAMS %R (14) -78.351
MFI (14) 23.552
RIGL Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

RIGL Price vs Max Options Open Interest
RIGL Max Change In Options Open Interest

RIGL Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

RIGL Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

RIGL Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

RIGL Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Rigel Pharmaceuticals Inc. (New) is above both the 50 Day and 200 Day SMA which is considered Bullish.

RIGL Moving Averages Analysis

Rigel Pharmaceuticals Inc. (New) has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 31, 2026

Rigel Pharmaceuticals Inc. (New) has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 31, 2026

RIGL (Rigel Pharmaceuticals Inc. (New)) Simple Moving Averages

Moving Averages are last updated Jul 31, 2026

Days MA
10 38.02
20 39.9
30 38.99
50 35.64
100 32.1
200 34.98

RIGL Fundamental Analysis

P/E (Forward) 8.673
P/E (Trailing) 2.0245
Market Cap ($) 704.2 million
Earnings/Share ($) 18.8
Net Profit Margin (%) 1.2151
Dividend/Share ($) --
EPS Estimate Current Year ($) 2.8931
EPS Estimate Next Year ($) 4.8324
WallStreet Target Price ($) 55.20
Most Recent Quarter